RESEARCH ARTICLE
Aminaphtone for Light Bleeding in Patients Under Oral Anticoagulation
José Maria Pereira de Godoy1, *, Gustavo Paludetto2, Bianca R Testoni2, Priscilla Yukiko Sano2
1 Angiology and Vascular Surgery Service of the Medicine School in São José do Rio Preto- SP (FAMERP)
2 Resident of the Angiology and Vascular Surgery Service of the Medicine School in São José do Rio Preto-SP (FAMERP)
Article Information
Identifiers and Pagination:
Year: 2010Volume: 4
First Page: 146
Last Page: 147
Publisher ID: TOCMJ-4-146
DOI: 10.2174/1874192401004010146
Article History:
Received Date: 6/5/2010Revision Received Date: 13/5/2010
Acceptance Date: 18/5/2010
Electronic publication date: 18/6/2010
Collection year: 2010
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
Background:
Bleeding is a common complication of oral anticoagulation therapy.
Objective:
The present study evaluated the use of aminaphtone in patients with minor bleeding while taking warfarin.
Methods:
Seven patients suffering from bleeding of the nose and gums, who were taking therapeutic doses of warfarin, were included in the study.
Results:
The patients were prescribed 75 mg aminaphtone twice daily. For 5 of these patients the bleeding was controlled within 48 h, for 1, within 96 h and for the other, a satisfactory reduction was obtained.
Conclusion:
Patients with minor bleeding during treatment using oral anticoagulation, who are free from risk of other complications, can benefit from the use of aminaphtone as an initial therapeutic option.
Keywords: Bleeding, Oral Anticoagulation, Warfarin, Aminaphtone, Treatment .
